Trial Profile
YONDELIS (Trabectedin) Single Patient Compassionate Use / Expanded Access in Soft Tissue Sarcoma.
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2011
Price :
$35
*
At a glance
- Drugs Trabectedin (Primary)
- Indications Sarcoma
- Focus Therapeutic Use
- 05 Sep 2011 New trial record